Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;20(3):196–200. doi: 10.1002/clc.4960200304

Depression and coronary heart disease: A review for cardiologists

Robert M Carney 1,, Kenneth E Freedland 1, Yvette I Sheline 1, Edward S Weiss 2
PMCID: PMC6655605  PMID: 9068903

Abstract

Major depression is a common comorbid condition in patients with coronary heart disease (CHD). Although mild emotional distress may be a normal reaction to myocardial infarction or other manifestations of CHD, major depression should not be considered a normal reaction, nor should it be ignored. Major depression is a debilitating comorbid disorder that can seriously complicate recovery and increase the risks of further cardiac morbidity and mortality. Fortunately, it is one that can be successfully treated in the majority of cases. The purpose of this review is to present the evidence for the negative prognostic effects of depression in cardiac patients and to discuss methods for assessing and treating depression in these patients.

Keywords: depression, coronary heart disease, emotional distress, treatment

Full Text

The Full Text of this article is available as a PDF (615.1 KB).

References

  • 1. Cassem H, Hackett TP: Psychiatric consultation in a coronary care unit. Ann Intern Med 1971; 75: 9–14. [DOI] [PubMed] [Google Scholar]
  • 2. Cay EL, Vetter N, Philip AE, Dugard P: Psychological status during recovery from an acute heart attack. J Psychosom Res 1972; 16: 425–435. [DOI] [PubMed] [Google Scholar]
  • 3. Croog SH, Levine S: Life after Heart Attack. New York: Human Sciences Press Inc., 1982. [Google Scholar]
  • 4. Carney RM, Freedland KE, Jaffe AS: Insomnia and depression prior to myocardial infarction. Psychosom Med 1990; 52: 603–609. [DOI] [PubMed] [Google Scholar]
  • 5. Forrester AW, Lipsey JR, Teitelbaum ML, DePaulo JR, Andrzejewski PL, Robinson RG: Depression following myocardial infarction. Int J Psychiatry Med 1992; 22: 33–46. [DOI] [PubMed] [Google Scholar]
  • 6. Ladwig KH, Lehmacher W, Roth R, Breithhardt G, Budde T, Borggrefe M: Factors which provoke post‐infarction depression: Results from the post‐infarction late potential study. J Psychosom Res 1992; 36: 723–729. [DOI] [PubMed] [Google Scholar]
  • 7. Schleifer SJ, Macari‐Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin R, Zucker HD: The nature and course of depression following myocardial infarction. Arch Intern Med 1989; 149: 1785–1789. [PubMed] [Google Scholar]
  • 8. Carney RM, Rich MW, Tevelde AJ, Freedland KE, Saini J, Simeone C, Clark K: Major depressive disorders in coronary artery disease. Am J Cardiol 1987; 60: 1273–1275. [DOI] [PubMed] [Google Scholar]
  • 9. Blazer DTG, Keller RC, McGonagle KA, Swartz MS: The prevalence and distribution of major depression in a national community sample: The national comorbidity survey. Am J Psychiatry 1994; 151: 979–986. [DOI] [PubMed] [Google Scholar]
  • 10. American Psychiatric Association : Diagnostic and statistical manual of mental disorders (4th edition, revised). Washington, D.C. (1994).
  • 11. Stern JJ, Pascale L, Ackerman A: Life adjustment post myocardial infarction: Determining predictive variables. Arch Intern Med 1977; 137: 1680–1685. [PubMed] [Google Scholar]
  • 12. Travella JI, Forrester AW, Schultz SK, Robinson RG: Depression following myocardial infarction: A one year longitudinal study. Int J Psychiatry Med 1994; 24 (suppl 4): 357–369. [DOI] [PubMed] [Google Scholar]
  • 13. Hance M, Carney RM, Freedland KE, Skala J: Depression in patients with coronary heart disease: A twelve‐month follow‐up. Gen Hosp Psychiatry, 1995; 18: 61–65. [DOI] [PubMed] [Google Scholar]
  • 14. Wells KB, Burnam MA, Rogers W, Hays R, Camp P: The course of depression in adult outpatients. Results from the Medical Outcomes Study. Arch Gen Psychiatry 1992; 49: 788–794. [DOI] [PubMed] [Google Scholar]
  • 15. Wells KB, Stewart A, Hays R, Burnam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J: The functioning and well‐being of depressed patients. Results from the Medical Outcomes Study. J Am Med Assoc 1989; 262: 914–919. [PubMed] [Google Scholar]
  • 16. Ormel J, VonKorff M, Ustun TB, Pini S, Korten A, Oldehinkel T: Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. J Am Med Assoc 1994; 272: 1741–1748. [DOI] [PubMed] [Google Scholar]
  • 17. Lloyd GG, Cawley RH: Distress or illness? A study of psychosocial symptoms after myocardial infarction. Br J Psychiatry 1983; 142: 120–125. [DOI] [PubMed] [Google Scholar]
  • 18. Mayou R, Foster A, Williamson B: Psychosocial adjustment in patients one year after myocardial infarction. J Psychosom Res 1978; 22: 447–453. [DOI] [PubMed] [Google Scholar]
  • 19. Bryant B, Mayou R: Prediction of outcome after coronary artery surgery. J Psychosom Res 1989; 33: 419–427. [DOI] [PubMed] [Google Scholar]
  • 20. Skala JA, Freedland KE, Carney RM: Depressive symptoms and functional status in patients with congestive heart failure. Ann Behavior Med 1995; 17: S130. [Google Scholar]
  • 21. Carney RM, Rich MW, Tevelde A, Saini J, Clark K, Jaffe AS: Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988; 50: 627–633. [DOI] [PubMed] [Google Scholar]
  • 22. Schleifer SJ, Macari MM, Slater W, Kahn M, Zucker H, Gorlin R: Predictors of outcome after myocardial infarction: Role of depression. Circulation 1974; 2: 2–10. [Google Scholar]
  • 23. Frasure‐Smith N, Lespérance F, Talajic M: Depression following myocardial infarction. Impact on 6‐month survival. J Am Med Assoc 1993; 270: 1819–1825. [PubMed] [Google Scholar]
  • 24. Kennedy GJ, Hofer MA, Cohen D, Shindledecker MA, Fisher JD: Significance of depression and cognitive impairment in patients undergoing programmed stimulation of cardiac arrythmias. Psychosom Med 1987; 49: 410–421. [DOI] [PubMed] [Google Scholar]
  • 25. Ahern DK, Gorkin L, Anderson JL, Tierney C, Hallstrom A, Ewart C, Capone RJ, Schron E, Kornfeld D, Herd JA: Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 1990; 66: 59–62. [DOI] [PubMed] [Google Scholar]
  • 26. Ladwig KH, Kieser M, Konig J, Breithardt G, Borggrefe M: Affective disorders and survival after myocardial infarction. Results from the postinfarction late potential study. Eur Heart J 1991; 12: 959–964. [PubMed] [Google Scholar]
  • 27. Esler M, Turbott J, Schwarz R, Leonard P, Bobik A, Skews H, Jackman G: The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry 1982; 39: 295–300. [DOI] [PubMed] [Google Scholar]
  • 28. Roy A, Pickar D, De Jong J, Karoum F, Linnoila M: Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Arch Gen Psychiatry 1988; 45: 849–857. [DOI] [PubMed] [Google Scholar]
  • 29. Siever LI, Davis KL: Overview: Toward a dysregulation hypothesis of depression. Am J Psychiatry 1985; 142: 1017–1031. [DOI] [PubMed] [Google Scholar]
  • 30. Hjemdahl P, Larrson T, Wallen NH: Effects of stress and B‐blockade on platelet function. Circulation 1991; 84 (suppl 4): 44–61. [PubMed] [Google Scholar]
  • 31. Podrid PJ, Fuchs T, Candinas R: Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 1990; 82 (suppl 1): 103–110. [PubMed] [Google Scholar]
  • 32. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS: Depression is associated with reduced heart rate variability in patients with coronary heart disease. Am J Cardiol 1995; 76: 562–564. [DOI] [PubMed] [Google Scholar]
  • 33. Carney RM, Freedland KE, Rich MW, Smith LJ, Jaffe AS: Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med 1993; 95: 23–28. [DOI] [PubMed] [Google Scholar]
  • 34. Kurosawa H, Shimizu Y, Nishimatsu Y, Hirose S, Takano T: The relationship between mental disorders and physical severities in patients with acute myocardial infarction. Jpn Circ Res 1983; 47: 723–728. [DOI] [PubMed] [Google Scholar]
  • 35. Rifkin A: Depression in physically ill patients. Don't dismiss it as understandable. Postgrad Med 1992; 92 (suppl 3): 146–154. [DOI] [PubMed] [Google Scholar]
  • 36. Freedland KE, Lustman PJ, Carney RM, Hong BA: Underdiagnosis of depression in patients with coronary artery disease: The role of nonspecific symptoms. Int J Psychiatry Med 1992; 22: 221–229. [DOI] [PubMed] [Google Scholar]
  • 37. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–571. [DOI] [PubMed] [Google Scholar]
  • 38. Spitzer RL, Williams JBW, Kroenke K: Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME‐MD 1000 study. J Am Med Assoc 1994; 272: 1749–1756. [PubMed] [Google Scholar]
  • 39. Pary RP, Tobias CR, Lippmann S: Antidepressants and the cardiac patient: Selecting an appropriate medication. Postgrad Med 1989; 85 (suppl 1): 267–269. [DOI] [PubMed] [Google Scholar]
  • 40. Giardina EGV, Bigger JT Jr, Johnson LL: The effect of imipramine and nortriptyline on ventricular premature depolarizations and left ventricular function. Circulation 1981; 64 (suppl 4): 316. [Google Scholar]
  • 41. Glassman AH, Roose SP: Delusional depression: A distinct clinical entity? Arch Gen Psychiatry 1981; 38: 424–427. [DOI] [PubMed] [Google Scholar]
  • 42. Glassman AH, Roose SP, Giardina EGV: Cardiovascular effects of tricyclic antidepressants In Psychopharmacology: The Third Generation of Progress (Ed. Meltzer HY.), p. 1437–1442. New York: Raven Press, 1987. [Google Scholar]
  • 43. Glassman AH, Bigger JT Jr: Cardiovascular effects of therapeutic doses of tricyclic antidepressants: A review. Arch Gen Psychiatry 1981; 38: 815–820. [DOI] [PubMed] [Google Scholar]
  • 44. Roose SP, Glassman AH, Giardina EGV, Johnson LL, Walsh T, Bigger JT Jr: Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. J Clin Psychopharmacol 1987; 7 (suppl 4): 247–251. [PubMed] [Google Scholar]
  • 45. Bigger JT Jr, Giardina EGV, Perel JM, Kantor SJ, Glassman AH: Cardiac antiarrhythmic effect of imipramine hydrochloride. N Engl J Med 1977; 296: 206–208. [DOI] [PubMed] [Google Scholar]
  • 46. Finkel MS, Gaffney A, Laghrissi‐Thode F, Pollock BG, Kennedy J, Nelson C, Gergel I, McCafferty JP, Roose SP: Randomized trial of antidepressants in patients with ischemic heart disease (abstr). J Am Coll Cardiol 1996; 27 (2a): 186a. [Google Scholar]
  • 47. Glassman AH, Roose SP, Bigger JT Jr: The safety of tricyclic antidepressants in cardiac patients. Risk‐benefit considered. J Am Med Assoc 1993; 269: 2673–2675. [PubMed] [Google Scholar]
  • 48. Nemeroff CB, DeVane CL, Pollock BG: Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996; 153: 311–320. [DOI] [PubMed] [Google Scholar]
  • 49. Ormel J, VonKorff M, vanden Brink W, Katon W, Brielman E, Oldehinkel T: Depression, anxiety and disability show synchrony of change. Am J Publ Health 1993; 83: 385–390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. VonKorff M, Ormel J, Katon W, Lin EHB: Disability and depression among high utilizers of health care: A longitudinal analysis. Arch Gen Psychiatry 1992; 49: 91–100. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES